Hepatobiliary Disease
📧 Sign up to get email alerts when something new happens for Hepatobiliary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Time to Post-operative Recovery of Serum Albumin as a Predictor of Outcome in Major Hepato Pancreato Biliary Surgeries
This clinical trial evaluates whether the time to postoperative recovery of serum albumin can predict outcomes after major hepatopancreatobi…
-
FDA approval · 2022-11-22FDA Approved: SINCALIDE — Original Application (MAIA Pharmaceuticals, Inc.)
FDA approved an Original Application for Sincalide (sincalide) by MAIA Pharmaceuticals, Inc., authorizing its use as a diagnostic agent for …
-
CLINICAL_TRIALS trial_result · 2017-12-14Clinical Trial Update: Usefulness of BiClamp Forceps for Liver Resection: A Randomized Clinical Trial [Phase 3]
A Phase 3 randomized trial evaluating BiClamp forceps for liver resection has been completed; results were posted in 2017.
-
FDA approval · 2016-02-17FDA Approved: KINEVAC — Supplemental Application (Bracco Diagnostics Inc.)
FDA approved a supplemental application for KINEVAC (sincalide) submitted by Bracco Diagnostics Inc.
-
FDA approval · 2015-08-18FDA Approved: KINEVAC — Supplemental Application (Bracco Diagnostics Inc.)
FDA approved a supplemental application for KINEVAC (sincalide) submitted by Bracco Diagnostics Inc., indicating approval of changes under a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2010-08-12FDA Approved: KIT FOR THE PREPARATION OF TECHNETIUM TC 99M MEBROFENIN — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approves a supplemental application for a kit to prepare Technetium-99m mebrofenin for hepatobiliary imaging, manufactured by Sun Pharma…